Vikram Thermo (India) Ltd. (BSE: 530477) is an Ahmedabad, Gujarat-based company in the Medicinal Chemicals and Botanical Products industry. With a market capitalisation of ₹994 Cr, it ranks #1,587 by market cap among the 6,197 Indian listed companies on FinBizNet, and #47 of 86 in Medicinal Chemicals and Botanical Products. At ₹320.15 (as of 16 Nov 2026), the share price is 31.1% below its 52-week high of ₹464.70 and 140.4% above its 52-week low of ₹133.20. The share price is up 82.4% over one year and up 15.9% over three months.
| Current Price | ₹320.15 |
|---|---|
| Market Cap | ₹994 Cr |
| BSE Code | 530477 |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals |
| Sub-Industry | Biotechnology and Life Sciences > Medicinal Chemicals and Botanical Products |
| P/E Ratio | 25.8 |
| Return on Equity | 7.17% |
| Return on Assets | 19.13% |
| 52-Week Range | ₹133.20 – ₹464.70 |
| 1-Year Price Change | +82.4% |
| 3-Month Price Change | +15.9% |
| Beta (1Y) | 0.67 |
| Dividend Yield | 0.39% |
| Headquarters | Ahmedabad, Gujarat |
| Website | www.vikramthermo.com |
Delivery averaged 68.4% of traded volume across 15 BSE sessions (21 Oct 2026 – 13 Nov 2026).
Vikram Thermo (India) Limited engages in the manufacture, marketing, and export of pharmaceutical excipients and chemicals in India and internationally. The company offers pharmaceutical polymer products, such as DRUGCOAT, a methacrylic co-polymer-based pharma polymer used for enteric and protective coating, taste masking, and sustained release formulation; DRCOAT, provides aqueous and non-aqueous based tablet coating system; and diphenyl oxide, an aromatic chemical. It also provides cosmetic polymers comprising AQUAPOL polymer, an acrylic acid polymer; and APION cross-linked polymers. The company was founded in 1985 and is based in Ahmedabad, India.
1. Manufacturing of Chemicals-This segment manufactures and markets pharmaceutical excipients and chemicals.
1. Pharma Polymers-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹4,56,425 Cr | 39.5 | 14.72% | ₹16,199 Cr | +11.2% |
| Laurus Labs Ltd | ₹1,31,242 Cr | 145.6 | 17.74% | ₹2,206 Cr | +146.8% |
| Zydus Lifesciences Ltd | ₹1,19,651 Cr | 24.1 | 18.32% | ₹7,910 Cr | +26.0% |
| Dr.Reddys Lab | ₹1,15,464 Cr | 26.9 | 11.52% | ₹8,698 Cr | +14.5% |
| Cipla Limited | ₹1,14,712 Cr | 29.3 | 11.74% | ₹7,404 Cr | -7.6% |
| Mankind Pharma | ₹1,09,870 Cr | 57 | 12.45% | ₹4,338 Cr | +16.7% |
| Aurobindo Pharma Ltd. | ₹1,05,150 Cr | 30 | 9.93% | ₹10,263 Cr | +59.8% |
| Lupin Ltd | ₹92,087 Cr | 17.3 | 26.91% | ₹7,827 Cr | +0.4% |
| Vikram Thermo (India) Ltd. | ₹994 Cr | 25.8 | 7.17% | — | +82.4% |
Listed by market capitalisation. Ratios are shown for context only.
Vikram Thermo (India) Ltd. is trading at ₹320.15, with a market capitalisation of ₹994 Cr.
Vikram Thermo (India) Ltd. operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Biotechnology and Life Sciences > Medicinal Chemicals and Botanical Products).
Vikram Thermo (India) Ltd. has a P/E of 25.8 and a return on equity of 7.17%.
Vikram Thermo (India) Ltd. is listed on the BSE under the scrip code 530477.
Vikram Thermo (India) Ltd.'s share price is up 82.4% over one year and up 15.9% over three months. Its 52-week range is ₹133.20 to ₹464.70.
Data as of 16 Nov 2026. Descriptive market data only — not investment advice.